Biofilm-Associated Immune Vulnerability in Streptococcus pneumoniae: Virulence-Factor Remodeling and Therapeutic Implications for Invasive Disease

Abstract

Streptococcus pneumoniae biofilms contribute to persistent carriage, immune evasion, and progression to invasive disease. Recent studies indicate that the biofilm state alters the display and function of key surface-associated virulence factors, including PspA, PspC, and LytA, and may reduce susceptibility to complement-mediated clearance and phagocytosis. At the same time, biofilm-dispersed pneumococci appear to elicit stronger innate immune activation than planktonic cells, suggesting that transition out of biofilm may expose a biologically vulnerable state. This review synthesizes recent peer-reviewed evidence on pneumococcal biofilm-associated immune interactions, focusing on virulence-factor remodeling, host recognition, and implications for therapy. Literature supports a state-dependent model of pathogenesis in which biofilm growth promotes persistence, whereas dispersion may increase immune visibility. However, current studies are heterogeneous in model system, assay design, and outcome measures, limiting direct quantitative synthesis. Standardized biofilm phenotyping and clinically linked validation studies are needed to determine whether biofilm-targeted or state-aware interventions can improve outcomes in invasive pneumococcal disease.